Equistone Partners Europe

Equistone Partners Europe is a European private equity firm with offices in England, France, Switzerland and Germany, which was created in 2011 by splitting off from the British Barclays Bank.

Business

The Barclays was founded in 1979 by Barclays Bank Private Equity invested primarily in medium-sized companies with sales of between about 50 and 500 million euros. Since the European regulators are pushing for a higher capital adequacy of investment companies since the financial crisis after 2007, several European banks have become independent of their private equity offshoot. In November 2011, Barclays announced the elimination of the Barclays Private Equity in a management buyout announced the new name of the company was Equistone Partners Europe.

In addition to representation in the UK (London, Manchester and Birmingham), there are offices in France (Paris), Germany (Munich, 1998 ) and Switzerland ( Zurich ).

Investments

Equistone maintains active interests in Eschenbach Optik, Sunrise Medical, Konrad Hornschuch AG and CU Chemie Uetikon GmbH.